BioNote, Inc. (KRX: 377740)
South Korea
· Delayed Price · Currency is KRW
4,720.00
+85.00 (1.83%)
Nov 15, 2024, 9:00 AM KST
BioNote Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | 81,651 | -20,497 | 307,798 | 676,601 | 528,229 | 20,613 |
Depreciation & Amortization | 8,104 | 8,206 | 6,451 | 4,106 | 1,887 | 1,410 |
Loss (Gain) From Sale of Assets | -152.19 | -265.2 | -13,412 | -361,225 | 11.45 | 200.91 |
Asset Writedown & Restructuring Costs | - | 8,409 | - | - | - | - |
Loss (Gain) From Sale of Investments | 2,745 | 5,000 | 5,150 | -15,047 | -544.38 | -15,645 |
Loss (Gain) on Equity Investments | 28,324 | 83,791 | -77,260 | - | -142,571 | - |
Stock-Based Compensation | 39.97 | - | 1,637 | 1,985 | 348.06 | - |
Provision & Write-off of Bad Debts | -5,146 | -2,845 | -3,596 | 6,827 | 470.16 | -180.02 |
Other Operating Activities | -77,880 | -82,440 | -4,089 | 34,137 | 172,526 | 4,158 |
Change in Accounts Receivable | 4,167 | 855.57 | 73,437 | 220,048 | -305,480 | -1,706 |
Change in Inventory | 10,409 | -436.63 | -33,543 | -9,826 | -48,141 | 158.9 |
Change in Accounts Payable | -275.62 | 221.23 | -4,573 | -22,140 | 27,513 | 469.16 |
Change in Other Net Operating Assets | -1,434 | -4,193 | -8,901 | 1,926 | 5,679 | 372.43 |
Operating Cash Flow | 50,550 | -4,194 | 249,100 | 537,392 | 239,926 | 9,851 |
Operating Cash Flow Growth | 11.16% | - | -53.65% | 123.98% | 2335.49% | - |
Capital Expenditures | -7,620 | -3,963 | -42,266 | -51,425 | -26,698 | -1,518 |
Sale of Property, Plant & Equipment | 406.77 | 94.36 | 49,399 | 174.43 | 78.08 | - |
Cash Acquisitions | - | - | - | -6,266 | - | - |
Sale (Purchase) of Intangibles | -65.86 | -579.33 | -217.44 | -118.58 | -23.59 | -10.16 |
Investment in Securities | 197,563 | -477,108 | -37,446 | -133,747 | -84,749 | -32,374 |
Other Investing Activities | 0 | 0 | - | - | - | 10 |
Investing Cash Flow | 190,283 | -481,555 | -30,530 | -191,383 | -111,393 | -33,893 |
Short-Term Debt Issued | - | 150,000 | - | - | - | 11,600 |
Long-Term Debt Issued | - | 10.5 | 50 | - | - | - |
Total Debt Issued | 150,011 | 150,011 | 50 | - | - | 11,600 |
Short-Term Debt Repaid | - | -150,000 | - | - | -12,000 | -21,600 |
Long-Term Debt Repaid | - | -836 | -415.58 | -216.76 | -79.83 | -43.51 |
Total Debt Repaid | -151,094 | -150,836 | -415.58 | -216.76 | -12,080 | -21,644 |
Net Debt Issued (Repaid) | -1,084 | -825.5 | -365.58 | -216.76 | -12,080 | -10,044 |
Issuance of Common Stock | 374.96 | 843.66 | 73,280 | - | - | 36,795 |
Dividends Paid | -20,411 | -49,919 | -49,959 | -49,959 | - | - |
Other Financing Activities | - | - | -0 | -420 | 415 | - |
Financing Cash Flow | -21,120 | -49,901 | 22,955 | -50,596 | -11,665 | 26,752 |
Foreign Exchange Rate Adjustments | 19,699 | 1,978 | 20,930 | 118.56 | -364.69 | -75.65 |
Net Cash Flow | 239,413 | -533,672 | 262,455 | 295,532 | 116,504 | 2,634 |
Free Cash Flow | 42,930 | -8,156 | 206,834 | 485,966 | 213,228 | 8,333 |
Free Cash Flow Growth | 248.08% | - | -57.44% | 127.91% | 2458.84% | - |
Free Cash Flow Margin | 45.15% | -9.05% | 43.12% | 78.09% | 33.77% | 20.81% |
Free Cash Flow Per Share | 420.19 | -79.88 | 2193.65 | 5186.94 | 2279.15 | 98.94 |
Cash Interest Paid | 676.15 | 602.82 | 84.44 | 44.25 | 165.72 | 468.26 |
Cash Income Tax Paid | 6,818 | 40,454 | 157,006 | 171,252 | 993.03 | 670.58 |
Levered Free Cash Flow | 20,777 | -18,697 | 129,964 | 399,410 | 150,205 | - |
Unlevered Free Cash Flow | 21,199 | -18,321 | 130,017 | 399,438 | 150,313 | - |
Change in Net Working Capital | -11,750 | -7,495 | 20,219 | -151,924 | 173,970 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.